Related Experiment Video
Updated: Aug 13, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 3, 2013
Prostate cancer screening. Why the controversy?
1Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Abstract:
The development of new technologies has stimulated a crusade of screening for earlier detection of prostate cancer. This effort has resulted in controversy regarding its clinical use in this format. Until randomized clinical screening trials define the value of prostate cancer screening, clinicians who use screening approaches must gain a strong understanding of the natural history of the disease, the strengths and weaknesses of available screening methodologies, and epidemiologic considerations of prostate cancer risk.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

